生体補綴市場：タイプ別、用途別-2025-2030年の世界予測

生体補綴市場は、2023年に59億7,000万米ドルと評価され、2024年には71億4,000万米ドルに達すると予測され、CAGR 19.61％で成長し、2030年には209億4,000万米ドルに達すると予測されています。

生体補綴は、損傷した組織や臓器を置換または修復するために設計された、生物学的材料で作られた医療用インプラントのセグメントを包含します。その必要性は、変性疾患、外傷、先天性欠損などの問題から生じ、従来の材料と比較してより適合性が高く、拒絶反応の少ない代替物への需要につながっています。用途としては、主に心臓血管手術、特に心臓弁、ヘルニア修復、その他の軟部組織の再建が挙げられます。最終用途分野は、病院、専門クリニック、外来手術センターなど多岐にわたり、これらのセンターでは、高度な手術オプションによって患者の転帰を改善することが常に課題となっています。主な成長促進要因としては、心血管疾患の有病率の増加、生体適合性の進歩、高齢化社会が挙げられます。新興国市場は、ヘルスケア・インフラ整備への注目の高まりと、高度な治療オプションに対する患者の意識の高まりにより、大きな可能性を秘めています。しかし、高コスト、厳しい規制環境、生物学的材料の使用に関連する倫理的懸念などの制約が、市場の進展を妨げる可能性があります。また、競合の激化や、開発者が超えなければならない合成代替品における技術的制約も課題となっています。組織工学、材料の生体適合性の向上、デジタルヘルスツールを統合したコンビネーションデバイスなどの分野でイノベーションを起こせば、ビジネス成長の有利な機会を提供することができます。耐久性の向上と免疫原性の低減に関する調査は、市場の受容性と適用性を拡大する上で極めて重要です。市場は本質的にダイナミックであり、世界の規制のシフトと技術の進歩に後押しされています。企業は、最先端の生体補綴ソリューションの研究開発に投資し、医療提供者と協力して、製品が現在のニーズと新たなニーズを満たすようにすべきです。認知度を高め、臨床試験を通じて安全性と有効性を証明することは、市場での地位を強化するために不可欠な戦略です。

市場力学：急速に進化する生体補綴市場の主要市場インサイトを公開

生体補綴市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 人口における心血管疾患の有病率の上昇
  • 各国におけるヘルスケア支出の増加
  • 形成外科および創傷治癒処置における生体補綴の重要な用途
• 市場抑制要因
  • 生体補綴手術に伴う高コスト
• 市場機会
  • 技術的進歩と組織工学的生体人工関節の急速な進化
  • 研究開発活動を後押しする新たな資金調達活動
• 市場の課題
  • バルブの耐久性と適合性に関する問題

ポーターの5つの力：生体補綴市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：生体補綴市場における外部からの影響の把握

外部マクロ環境要因は、生体補綴市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析生体補綴市場における競合情勢の把握

生体補綴市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス生体補綴市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、生体補綴市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨生体補綴市場における成功への道筋を描く

生体補綴市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 人口における心血管疾患の罹患率の上昇
    • 経済におけるヘルスケア費の増加
    • 整形外科手術および創傷治癒処置における生体補綴の重要な応用
  • 抑制要因
    • 生体補綴手術に伴う高額な費用
  • 機会
    • 組織工学バイオプロテーゼの技術的進歩と急速な進化
    • 研究開発活動を促進するための新たな資金調達活動
  • 課題
    • バルブの耐久性と互換性に関する問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 生体補綴市場：タイプ別

• 同種移植
• 牛
• 豚肉
• 異種移植

第7章 生体補綴市場：用途別

• 心臓血管
• 形成外科と創傷治癒

第8章 南北アメリカの生体補綴市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の生体補綴市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの生体補綴市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Anteris Technologies Ltd.
• Aortech International PLC
• Boston Scientific Corporation
• Braile Biomedica, Inc.
• Corcym UK Limited
• Edwards Lifesciences Corporation
• Foldax
• Getinge AB
• Hancock Jaffe Laboratories, Inc.
• Humacyte, Inc.
• JenaValve Technology GmbH
• Labcor Laboratorios Ltd.
• LeMaitre Vascular Inc.
• Life Cell Corporation
• LifeNet Health
• LivaNova, PLC
• Medical Devices Business Services, Inc.
• Medtronic PLC
• Organogenesis, Inc.
• Sorin Group
• Suzhou Jiecheng Medical Technology Co., Ltd
• Ziacom Medical

LIST OF FIGURES

• FIGURE 1. BIOPROSTHETICS MARKET RESEARCH PROCESS
• FIGURE 2. BIOPROSTHETICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOPROSTHETICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOPROSTHETICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIOPROSTHETICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIOPROSTHETICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. BIOPROSTHETICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. BIOPROSTHETICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOPROSTHETICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOPROSTHETICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOPROSTHETICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIOPROSTHETICS MARKET DYNAMICS
• TABLE 7. GLOBAL BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIOPROSTHETICS MARKET SIZE, BY ALLOGRAFT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOPROSTHETICS MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIOPROSTHETICS MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOPROSTHETICS MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIOPROSTHETICS MARKET SIZE, BY PLASTIC SURGERY & WOUND HEALING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. CANADA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. CANADA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. CHINA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. CHINA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. INDIA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. INDIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. ITALY BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. ITALY BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. POLAND BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. POLAND BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. QATAR BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. QATAR BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. BIOPROSTHETICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 102. BIOPROSTHETICS MARKET, FPNV POSITIONING MATRIX, 2023

The Bioprosthetics Market was valued at USD 5.97 billion in 2023, expected to reach USD 7.14 billion in 2024, and is projected to grow at a CAGR of 19.61%, to USD 20.94 billion by 2030.

Bioprosthetics encompass a segment of medical implants made from biological materials, designed to replace or repair damaged tissues or organs. Their necessity arises from issues like degenerative diseases, trauma, and congenital defects, leading to the demand for more compatible and less rejection-prone substitutes compared to traditional materials. Applications primarily include cardiovascular surgeries, particularly heart valves, hernia repair, and other soft tissue reconstructions. The end-use sectors are vast, spanning hospitals, specialty clinics, and ambulatory surgical centers, which are continually challenged to improve patient outcomes with advanced surgical options. Key growth drivers include the increasing prevalence of cardiovascular diseases, advancements in biocompatibility, and the aging population, which is more prone to conditions requiring such interventions. Emerging markets offer enormous potential due to an increasing focus on healthcare infrastructure development and rising patient awareness about advanced treatment options. However, limitations such as high costs, stringent regulatory environments, and ethical concerns related to the use of biological materials can hamper market progress. Challenges also stem from intense competition and technological constraints in synthetic alternatives that developers must surpass. Innovating in areas like tissue engineering, enhanced materials biocompatibility, and combination devices integrating digital health tools can provide lucrative opportunities for business growth. Research in improving durability and reducing immunogenicity is crucial for expanding market acceptance and applicability. The market is inherently dynamic, driven by regulatory shifts and technological advancements globally. Companies should invest in R&D for cutting-edge bioprosthetic solutions and collaborate with healthcare providers to ensure that products meet current and emerging needs. Building awareness and proving safety and efficacy through clinical trials are essential strategies to fortify market position.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bioprosthetics Market

The Bioprosthetics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of cardiovascular diseases among population
  • Increase in healthcare expenditure in economies
  • Significant applications of bioprosthetics in plastic surgery & wound healing procedures
• Market Restraints
  • High costs associated with bioprosthetic surgeries
• Market Opportunities
  • Technological advancement and rapid evolution of tissue-engineered bioprostheses
  • Emerging funding activities to boost research and development activities
• Market Challenges
  • Issues pertaining to valve durability and compatibility

Porter's Five Forces: A Strategic Tool for Navigating the Bioprosthetics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bioprosthetics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bioprosthetics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bioprosthetics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bioprosthetics Market

A detailed market share analysis in the Bioprosthetics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bioprosthetics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bioprosthetics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bioprosthetics Market

A strategic analysis of the Bioprosthetics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bioprosthetics Market, highlighting leading vendors and their innovative profiles. These include Anteris Technologies Ltd., Aortech International PLC, Boston Scientific Corporation, Braile Biomedica, Inc., Corcym UK Limited, Edwards Lifesciences Corporation, Foldax, Getinge AB, Hancock Jaffe Laboratories, Inc., Humacyte, Inc., JenaValve Technology GmbH, Labcor Laboratorios Ltd., LeMaitre Vascular Inc., Life Cell Corporation, LifeNet Health, LivaNova, PLC, Medical Devices Business Services, Inc., Medtronic PLC, Organogenesis, Inc., Sorin Group, Suzhou Jiecheng Medical Technology Co., Ltd, and Ziacom Medical.

Market Segmentation & Coverage

This research report categorizes the Bioprosthetics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Allograft, Bovine, Porcine, and Xenograft.
• Based on Application, market is studied across Cardiovascular and Plastic Surgery & Wound Healing.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of cardiovascular diseases among population
    • 5.1.1.2. Increase in healthcare expenditure in economies
    • 5.1.1.3. Significant applications of bioprosthetics in plastic surgery & wound healing procedures
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with bioprosthetic surgeries
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancement and rapid evolution of tissue-engineered bioprostheses
    • 5.1.3.2. Emerging funding activities to boost research and development activities
  • 5.1.4. Challenges
    • 5.1.4.1. Issues pertaining to valve durability and compatibility
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bioprosthetics Market, by Type

• 6.1. Introduction
• 6.2. Allograft
• 6.3. Bovine
• 6.4. Porcine
• 6.5. Xenograft

7. Bioprosthetics Market, by Application

• 7.1. Introduction
• 7.2. Cardiovascular
• 7.3. Plastic Surgery & Wound Healing

8. Americas Bioprosthetics Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Bioprosthetics Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Bioprosthetics Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Anteris Technologies Ltd.
• 2. Aortech International PLC
• 3. Boston Scientific Corporation
• 4. Braile Biomedica, Inc.
• 5. Corcym UK Limited
• 6. Edwards Lifesciences Corporation
• 7. Foldax
• 8. Getinge AB
• 9. Hancock Jaffe Laboratories, Inc.
• 10. Humacyte, Inc.
• 11. JenaValve Technology GmbH
• 12. Labcor Laboratorios Ltd.
• 13. LeMaitre Vascular Inc.
• 14. Life Cell Corporation
• 15. LifeNet Health
• 16. LivaNova, PLC
• 17. Medical Devices Business Services, Inc.
• 18. Medtronic PLC
• 19. Organogenesis, Inc.
• 20. Sorin Group
• 21. Suzhou Jiecheng Medical Technology Co., Ltd
• 22. Ziacom Medical